Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Novel drug STRIDES in the right direction for knee OA
21 Jun 2023
bởiAudrey Abella
In the phase III STRIDES X-Ray Extension study, additional doses of the investigational CLK/DYRK inhibitor lorecivivint delivered favourable outcomes for individuals with advanced knee osteoarthritis (OA).